Addressing Diversity in Clinical Trials

A recent FDA report encourages enrollment of more women and minorities in clinical trials.  Three priorities were identified in this report:

• Participation
• Data quality
• Transparency

This article looks at how contract research organizations (CROs) can help sponsors in each of these areas.